Cochlear Auditory Brainstem Implant System
Cochlear Americas · Decision date Apr 30, 2026
What did the FDA decide?
FDA records P000015/S056 as a supplement to PMA P000015, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 30, 2026.
FDA approval order statement
manufacturing process changes at Cochlear's supplier for the CP1110 sound processor rechargeable batteries
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Apr 30, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P000015/S056
- Regulatory pathway
- PMA supplement
- Applicant
- Cochlear Americas
- Product code
- MHE
- Decision code
- OK30
- Decision date
- Apr 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implant, auditory brainstem.
- Applicant
- Cochlear Americas
- Product code
- MHE
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P000015. Subsequent supplements may change the device or its indications.
FDA decision timeline
P000015 · Original PMA
NUCLEUS 24 AUDITORY BRAINSTEM IMPLANT SYSTEM
P000015/S056 received
Application receipt date recorded by FDA.
P000015/S056 · FDA decision
30-Day Notice
P000015/S057 · Related supplement
Cochlear Auditory Brainstem Implant System
Timeline entries are records held by MedtechLedger for P000015. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P000015
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cochlear Americas | PMA approval | Oct 20, 2000 | FDA | |
Cochlear Auditory Brainstem Implant SystemP000015/S057 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cochlear Americas
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 10350 Park Meadows Dr., Lone Tree, CO, 80124
Sources and methodology
- Original FDA record: P000015/S056
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records